Amdocs Ltd. Stock Plummets to New 52-Week Low of $58.23

Amdocs has reached a new 52-week low, trading at USD 58.23 as of June 8, 2026. This marks a significant decline for the small-cap company, which operates in the Computers - Software & Consulting industry. Over the past year, Amdocs has experienced a performance drop of 24.64%, contrasting sharply with the S&P 500's gain of 23.42%. Despite its recent struggles, Amdocs maintains a market capitalization of USD 17,047 million and exhibits a price-to-earnings ratio of 27.00. The company has demonstrated strong management efficiency, reflected in a return on equity of 18.45%. Additionally, Amdocs is net-debt free, which positions it favorably in terms of financial stability. However, the company has faced challenges in long-term growth, with net sales increasing at an annual rate of just 1.68% over the past five years. The stock's price-to-book ratio stands at 4.98, indicating a premium valuation compared to historical averages. Amdocs' performance has been below par in both the near and long term, as evidenced by its negative returns over the past year and its underperformance relative to the S&P 500 across multiple time frames.